Veradermics, Incorporated (MANE)
NYSE: MANE · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2020
Who owns Veradermics, Incorporated
As filed with the SECHolders of 5% or more
4
Patrick G. Enright holds 11.3% of Common Stock, $0.00001 par value per share, as its SCHEDULE 13D/A filed May 5, 2026 says.
Directors and officers
16
report now, of 16 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Patrick G. Enright
SCHEDULE 13D/A · filed May 5, 2026 · Common Stock, $0.00001 par value per share · 12.5% in Feb 12, 2026
Montanova Capital, LLC
SCHEDULE 13D/A · filed Aug 21, 2026 · Common Stock, par value $0.00001 · 9.9% in May 5, 2026
Fmr LLC
SCHEDULE 13G · filed Aug 6, 2026 · COMMON STOCK
JPMorgan Chase & Co.
SCHEDULE 13G · filed Oct 13, 2026 · Common stock, par value $0.00001 per share
SR One Capital Management, LLC
SCHEDULE 13D/A · filed Aug 14, 2026 · Common Stock, $0.00001 par value per share · reported falling below 5%, from 6.4% in Feb 11, 2026
Viking Global Investors LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%, from 5.8% in Feb 12, 2026
Citadel Advisors LLC
SCHEDULE 13G · filed May 7, 2026 · Common Stock, par value $0.00001 per share (the "Shares") · reported falling below 5%
Seven Fleet Master Fund LP
SCHEDULE 13D · filed May 5, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%
What MANE reports owning in othersstakes of 5% or more, and other ties
Veradermics, Incorporated reports no stake in another company in the record.
Insider tradesForm 4
15sales
25purchases
10sales on a scheduled plan
4people selling
$103Msold, in dollars
$40.8Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Averill Master Fund, Ltd. | director | 2 | $80.4M | 0 | 0 | $0 |
| Childs John W | director | 3 | $10.7M | 0 | 2 | $10.0M |
| Waldman Reid Alexander | Chief Executive Officer | 5 | $7.3M | 5 | 0 | $0 |
| Durso Timothy August | Chief Technical Officer | 5 | $4.7M | 5 | 0 | $0 |
| Suvretta Capital Management, LLC | director | 0 | $0 | 0 | 19 | $10.5M |
| Coric Vlad | director | 0 | $0 | 0 | 2 | $2.0M |
| Enright Patrick G | director | 0 | $0 | 0 | 2 | $18.3M |
| Longitude Venture Partners V, L.P. | 10% owner | 0 | $0 | 0 | 2 | $18.3M |